| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000022799 |
| Receipt No. | R000026276 |
| Scientific Title | The study to compare the hypoxic imaging of 18F-FAZA-PET/CT with the glucose metabolic imaging of 18F-FDG-PET/CT in patients with tumor |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2019/07/11 (Ver. 8) |
| Basic information | ||
| Public title | The study to compare the hypoxic imaging of 18F-FAZA-PET/CT with the glucose metabolic imaging of 18F-FDG-PET/CT in patients with tumor | |
| Acronym | The comparison study between 18F-FAZA-PET/CT and 18F-FDG-PET/CT | |
| Scientific Title | The study to compare the hypoxic imaging of 18F-FAZA-PET/CT with the glucose metabolic imaging of 18F-FDG-PET/CT in patients with tumor | |
| Scientific Title:Acronym | The comparison study between 18F-FAZA-PET/CT and 18F-FDG-PET/CT | |
| Region |
|
|
| Condition | ||
| Condition | Malignant tumors | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The aim of this study is to examine the diagnostic, therapeutic and prognostic values of 18F-FAZA-PET/CT for patients with malignant tumor by comparing with 18F-FDG-PET/CT. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | We compare the18F-FAZA-PET/CT findings with 18F-FDG-PET/CT findings before and after therapy in patients with malignant tumor. |
| Key secondary outcomes | Assessment of changes of the visual findings of both PET/CT examinations before and after therapy
Assessment of changes of the quantitative parameters (SUV, MTV and TLG) of both PET/CT examinations before and after therapy |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Cluster |
| Blinding | Single blind -investigator(s) and assessor(s) are blinded |
| Control | Active |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The 18F-FAZA-PET/CT examination is performed in patient with malignant tumor before and after therapy | |
| Interventions/Control_2 | The 18F-FDG-PET/CT examination is performed in patient with malignant tumor before and after therapy | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with malignant tumor who will be performed treatment | |||
| Key exclusion criteria | Patients with malignant tumor who will not be performed treatment | |||
| Target sample size | 160 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nanpuh Hospital | ||||||
| Division name | Radiology | ||||||
| Zip code | 892-8512 | ||||||
| Address | 14-3 Nagata, Kagoshima, Japan | ||||||
| TEL | 099-226-9111 | ||||||
| toyo.nakajo@dolphin.ocn.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nanpuh Hospital | ||||||
| Division name | Radiology | ||||||
| Zip code | 892-8512 | ||||||
| Address | 14-3 Nagata, Kagoshima, Japan | ||||||
| TEL | 099-226-9111 | ||||||
| Homepage URL | |||||||
| toyo.nakajo@dolphin.ocn.ne.jp | |||||||
| Sponsor | |
| Institute | Nanpuh Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Nanpuh Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Nanpuh Hospital |
| Address | 14-3 Nagata, Kagoshima, Japan |
| Tel | 099-226-9111 |
| crc-kenkyu@nanpuh.or.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 南風病院(鹿児島県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 22 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000026276 |